Evidence from a study published in the January issue of Journal of Clinical Lipidology, reports inositol hexanicotinate (IHN) ineffective in managing high cholesterol. The study, which published clinical results comparing an extended-release form of niacin to IHN and a placebo, simultaneously confirms a wax-matrix form of extended release niacin can help lower cholesterol.
